Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2024 |
1
1
|
| 2024 |
Open access
3
4
|
| 2024 |
2
2
|
| 2023 |
Open access
8
8
1
|
| 2022 |
Open access
6
6
|
| 2022 |
Open access
35
30
4
|
| 2021 |
Open access
820
721
6
|
| 2020 |
Open access
36
33
2
|
| 2019 |
Open access
49
50
3
|
| 2019 |
14
13
1
|
| 2018 |
23
19
7
|
| 2017 |
Open access
2
2
|
| 2015 |
14
13
|
| 2011 |
1
1
|
Research
| Details | Registry | Status |
|---|---|---|
|
Nanoparticle cancer therapy Kempson, Ivan; Turnbull, Tyron |
US | Filed |
External engagement & recognition
| Organisation | Country |
|---|---|
| Australian Nuclear Science and Technology Organisation | AUSTRALIA |
| Australian Synchrotron | AUSTRALIA |
| Flinders University | AUSTRALIA |
| Royal Adelaide Hospital | AUSTRALIA |
| University of Adelaide | AUSTRALIA |
| University of Erlangen-Nuremberg | GERMANY |
| University of South Australia | AUSTRALIA |
Teaching & student supervision
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| Tumour cell population heterogeneity: Therapeutic challenges and opportunities | Current |
| Development of a tumour microenvironment sensitive polymeric nanoparticle to formulate multiple chemotherapy agents for cancer treatment | Completed |
| Investigation of radiosensitization mechanisms using gold and aluminium nanoparticles under clinical beam radiation in the 4T1 mouse model of breast cancer | Completed |
| Linking the intracellular journey of gold nanoparticles to protein expression changes in prostate cancer cells | Completed |
| Unravelling biochemical effects of radiosensitizing gold nanoparticles on cancer cells at the cell population, single-cell, and molecular levels | Completed |
